PL2340014T3 - Krople do oczu z difluprednatem do leczenia obrzęku plamki żółtej - Google Patents

Krople do oczu z difluprednatem do leczenia obrzęku plamki żółtej

Info

Publication number
PL2340014T3
PL2340014T3 PL10739716T PL10739716T PL2340014T3 PL 2340014 T3 PL2340014 T3 PL 2340014T3 PL 10739716 T PL10739716 T PL 10739716T PL 10739716 T PL10739716 T PL 10739716T PL 2340014 T3 PL2340014 T3 PL 2340014T3
Authority
PL
Poland
Prior art keywords
difluprednate
eye drop
macular edema
edema treatment
treatment
Prior art date
Application number
PL10739716T
Other languages
English (en)
Inventor
Hidetoshi Yamashita
Teiko Yamamoto
Sakiko Goto
Sachi Abe
Eriko Kirii
Atsushi Okumura
Original Assignee
Univ Yamagata
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yamagata filed Critical Univ Yamagata
Publication of PL2340014T3 publication Critical patent/PL2340014T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Botany (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL10739716T 2009-07-14 2010-07-14 Krople do oczu z difluprednatem do leczenia obrzęku plamki żółtej PL2340014T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009165924 2009-07-14
PCT/JP2010/062289 WO2011007893A1 (en) 2009-07-14 2010-07-14 Eye drop with difluprednate for macular edema treatment
EP10739716.8A EP2340014B1 (en) 2009-07-14 2010-07-14 Eye drop with difluprednate for macular edema treatment

Publications (1)

Publication Number Publication Date
PL2340014T3 true PL2340014T3 (pl) 2013-09-30

Family

ID=42646370

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10739716T PL2340014T3 (pl) 2009-07-14 2010-07-14 Krople do oczu z difluprednatem do leczenia obrzęku plamki żółtej

Country Status (13)

Country Link
US (3) US20110190250A1 (pl)
EP (1) EP2340014B1 (pl)
JP (1) JP5579079B2 (pl)
KR (1) KR101689847B1 (pl)
CN (3) CN107569494A (pl)
BR (1) BRPI1005380A2 (pl)
CA (1) CA2738151C (pl)
ES (1) ES2405779T3 (pl)
MX (1) MX2011005043A (pl)
PL (1) PL2340014T3 (pl)
RU (1) RU2572707C2 (pl)
TW (1) TW201105363A (pl)
WO (1) WO2011007893A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012096129A1 (ja) * 2011-01-14 2012-07-19 株式会社エス・ディー・エス バイオテック ４－（３－ブチニル）アミノピリミジン誘導体を含む農園芸用有害生物防除剤組成物
US20140018402A1 (en) * 2011-03-30 2014-01-16 Catholic University Industry Academic Cooperation Foundation Pharmaceutical composition for preventing or treating macular degeneration
CN103130857A (zh) * 2011-11-30 2013-06-05 天津金耀集团有限公司 二氟泼尼酯ⅱ晶型及其制备方法
CN103130859B (zh) * 2011-11-30 2015-12-02 天津金耀集团有限公司 二氟泼尼酯晶型i及其制备方法
CN105120875B (zh) * 2013-02-15 2018-01-09 千寿制药株式会社 包含锌的二氟泼尼酯乳液组合物
JP6572201B2 (ja) * 2013-03-15 2019-09-04 エアーピオ セラピューティクス インコーポレイテッド 眼疾患を処置するための組成物、製剤、および方法
JP2017528865A (ja) 2014-06-23 2017-09-28 ショット アクチエンゲゼルシャフトＳｃｈｏｔｔ ＡＧ 板状の別個の要素を有する蓄電システム、板状の別個の要素、並びにその製造方法、及びその使用
WO2016087311A2 (de) 2014-12-01 2016-06-09 Schott Ag Elektrisches speichersystem mit einem scheibenförmigen diskreten element, diskretes scheibenförmiges element, verfahren zu dessen herstellung sowie dessen verwendung
US20180177718A1 (en) * 2015-05-29 2018-06-28 Envisia Therapeutics, Inc. Implant for treatment of an ocular condition
RU2661621C2 (ru) * 2016-12-19 2018-07-17 Александр Николаевич Епихин Способ пролонгации и усиления терапевтического эффекта действия ингибиторов ангиогенеза при лечении неоваскулярных форм макулярных дегенераций
CN108014172A (zh) * 2017-12-29 2018-05-11 广州仁恒医药科技股份有限公司 一种含有二氟泼尼酯的药物组合物及其制备方法
KR20210012346A (ko) 2019-07-25 2021-02-03 심낙범 미세먼지 눈꺼풀 세정스틱
FI4027983T3 (fi) * 2019-09-11 2026-02-03 Adverum Biotechnologies Inc Silmän neovaskulaaristen sairauksien hoito afliberseptiä koodaavilla aav2-varianteilla
TW202607144A (zh) * 2024-07-16 2026-02-16 美商愛德維仁生物科技公司 使用編碼阿柏西普（ａｆｌｉｂｅｒｃｅｐｔ）之ａａｖ２變異體治療眼部新生血管性疾病的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU684115B2 (en) 1993-12-27 1997-12-04 Mitsubishi Chemical Corporation Ophthalmic suspension containing diflupredonate
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JP3410364B2 (ja) 1997-05-14 2003-05-26 千寿製薬株式会社 ジフルプレドナート含有組成物
EP0878197B1 (en) * 1997-05-14 2002-08-21 Senju Pharmaceutical Co., Ltd. Compositions containing difluprednate
US20050048099A1 (en) * 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
RU2005129276A (ru) * 2003-02-20 2006-01-27 Алькон, Инк. (Ch) Применение стероидов для лечения субъектов, страдающих заболеванием глаз
US20050226814A1 (en) * 2004-04-13 2005-10-13 Bausch & Lomb Incorporated Diagnostic method and kit for implantation of a sustained release drug-delivery implant with a steroid
AU2005271700B2 (en) * 2004-07-12 2010-11-11 Allergan, Inc. Opthalmic compositions and methods for treating ophthalmic conditions
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
WO2007025275A2 (en) 2005-08-25 2007-03-01 Psivida Inc. Control of induced elevated intraocular pressure
US20090105245A1 (en) * 2006-12-21 2009-04-23 Bingaman David P Methods for treating macular edema and ocular angiogenesis using an anti-inflammatory agent and a receptor tyrosine kinase inhibitor

Also Published As

Publication number Publication date
TW201105363A (en) 2011-02-16
JP2012533517A (ja) 2012-12-27
KR101689847B1 (ko) 2016-12-26
MX2011005043A (es) 2011-06-01
CN103705524A (zh) 2014-04-09
EP2340014B1 (en) 2013-04-24
BRPI1005380A2 (pt) 2016-02-10
CA2738151C (en) 2017-02-28
WO2011007893A1 (en) 2011-01-20
JP5579079B2 (ja) 2014-08-27
US10092514B2 (en) 2018-10-09
KR20120040683A (ko) 2012-04-27
US20180133153A1 (en) 2018-05-17
CN107569494A (zh) 2018-01-12
RU2011125640A (ru) 2013-08-20
CA2738151A1 (en) 2011-01-20
US20110190250A1 (en) 2011-08-04
US20150190340A1 (en) 2015-07-09
ES2405779T3 (es) 2013-06-03
RU2572707C2 (ru) 2016-01-20
EP2340014A1 (en) 2011-07-06
CN102170865A (zh) 2011-08-31
US9949926B2 (en) 2018-04-24

Similar Documents

Publication Publication Date Title
TWM386892U (en) Eye massager
IL222702A0 (en) Incontinence treatment
EP2760359A4 (en) METHOD FOR TREATING EYE STATES
EP2753275A4 (en) METHODS OF TREATING OCULAR CONDITIONS
IL229017A0 (en) Oxidative diseases of the retina
PL2621569T3 (pl) Urządzenie lecznicze
EP2484384A4 (en) OPHTHALMIC DROPS
GB2494275B (en) Turf treatment
PL2709577T3 (pl) Urządzenie do badania lub zabiegu na ludzkim oku
GB201112778D0 (en) Eye patch
IL218282A0 (en) Treatment of macular degeneration
GB0922231D0 (en) Ocular Device
ZA201308117B (en) Avian-based treatment
ZA201404542B (en) Fabric treatment composition
GB2487262B (en) Turf treatment
GB201102283D0 (en) Treatment
GB201112345D0 (en) Insecticidal treatment
GB0913142D0 (en) Textile treatment
GB201112719D0 (en) Textile treatment
TWM372717U (en) Eye massage device
GB0914047D0 (en) Easy eye
TWM369758U (en) Nano-energetic eye mask
GB201012555D0 (en) Textile treatment
GB0913711D0 (en) Kerb eye
GB201102267D0 (en) Treatment